Abnormal albuminuria (spot urine ACR > 5.6 mg/mmol) predicted increased mortality (RR 7.1, P<0.001) and was associated with deterioration of renal function in Chinese patients with NIDDM.
Cohort (n=403)
Does abnormal albuminuria predict mortality and renal impairment in Chinese patients with NIDDM?
Abnormal albuminuria assessed by random spot urine ACR strongly predicts mortality and renal function deterioration in Chinese patients with NIDDM.
Relative Risk: 7.1
p-value: p=<0.001
OBJECTIVE: Microalbuminuria predicts mortality in non-insulin-dependent diabetes mellitus (NIDDM), but its association with deterioration of renal function remains more controversial than in insulin-dependent diabetes mellitus (IDDM). Using albumin-to-creatinine ratios (ACRs) in random spot urine samples is a convenient method for evaluating albuminuria. We studied prospectively the predictive values of albuminuria in NIDDM when assessed by this urine measurement. RESEARCH DESIGN AND METHODS: Between 1991 and 1992, we restudied the clinical and biochemical status of 403 Chinese NIDDM patients recruited in 1989 after a follow-up period of 26.6 +/- 3.2 months (mean +/- SD). Spot urine ACR was measured on two occasions and microalbuminuria was defined as a mean ACR between 5.6 and 38 mg/mmol. RESULTS: From the original cohort, 29 patients had died mostly because of cardiovascular events with or without renal failure. The overall relative risk of death in patients with abnormal albuminuria was 7.1 (P 5.6 mg/mmol predicts increased mortality and is associated with the progression of albuminuria and deterioration of renal function in Chinese NIDDM patients.
Chan et al. (1995) conducted a cohort in Non-insulin-dependent diabetes mellitus (NIDDM) (n=403). Abnormal albuminuria (spot urine ACR > 5.6 mg/mmol) vs. Normoalbuminuria was evaluated on Mortality (RR 7.1, p=<0.001). Abnormal albuminuria (spot urine ACR > 5.6 mg/mmol) predicted increased mortality (RR 7.1, P<0.001) and was associated with deterioration of renal function in Chinese patients with NIDDM.